Skip to main content
Fig. 6 | RESPIRATORY RESEARCH

Fig. 6

From: SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients

Fig. 6

SOX30 is an early-stage prognostic biomarker of ADC and SCC patients. a Survival analysis of SOX30 expression in 227 ADC patients split into two groups. Survival analyses were evaluated by Kaplan-Meier survival curve and multivariate Cox regression. HR represents hazard ratio. b Survival analysis of SOX30 expression in 200 SCC patients split into two groups. Survival analyses were evaluated by Kaplan-Meier survival curve and multivariate Cox regression. c Survival analysis of SOX30 expression in 112 stage I ADC patients split into two groups. Survival analyses were performed using Kaplan-Meier and Cox regression methods. d Survival analysis of SOX30 expression in 75 stage I SCC patients split into two groups. Survival analyses were tested by Kaplan-Meier and Cox regression methods

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us